INTRODUCTION
Human serum albumin (HSA) is the most abundant serum protein in the body of all vertebrates, with a typical concentration of 5 g/100 mL in the bloodstream and forming about 60% of the mass of plasma proteins (1, 2) . This protein is a singlechain 66 kDa protein, which is largely α-helical, and consists of three structurally homologous domains (I-III) each of which is divided into two subdomains (A and B) (3, 4) . Similar to most of the plasma proteins, albumin synthesizes in the liver where it is produced at a rate of approximately 0.7 mg/h for every gram of liver. This protein has an average half-life of 19 days (5) . Albumin is known to bind and transport many ligands, including fatty acids, amino acids, steroids, metal ions, bilirubin, colic acid, thyroid hormones and a variety of pharmaceuticals (6) (7) (8) (9) . Also, HSA acts as a buffer for the free drugs concentration (10) .
Some properties of HSA, like as well as its preferential uptake in tumor and inflamed tissue, its ready availability, its biodegradability, and its lack of toxicity and immunogenicity make it an ideal candidate for drug delivery (11, 12) . The degree of binding between a drug and plasma proteins can govern its distribution into tissues, affect its elimination from the body, and, consequently, affect its therapeutic or toxic effects. Then, it is suggested that only the unbound form of a drug interacts with its receptor to produce a pharmacological effect (13) .
Platinum (II) complexes including cis-platin and carboplatin are widely used in the treatment of several human malignant diseases, such as ovarian, testicular, lung, urinary bladder, head and neck cancer (14, 15) . Previous reports have been represented that the binding of platinum complexes to the N7-nitrogens of two adjacent guanosine bases is thought to disrupt DNA duplication leading to cell death. Also, Platinum complexes can react with many other cell components including glutathione and other S-containing biomolecules, present in relatively high doses inside the cell (16) (17) (18) .
Since albumin plays a central role in the molecular pharmacology of drugs used in cancer chemotherapy and also, the binding of drugs to HSA is particularly important because it affects both the activity of drugs and their disposition (19) . Then, in the present study, we have decided to investigate the binding of a new synthesized Pt(II) complex (2,2'-bipyridin Butylglycinato Pt(II) nitrate, Fig. 1 ), as anti-cancer drug, with blood carrier protein of HSA at different temperatures of 27 (room temperature), 37 (physiologic temperature), 42 (fever temperature) and 47 o C (upper fever temperature). Also, the cytotoxicity and anti proliferativity of this complex have checked against cancer model cell line of K562 at different incubation time.
RESULTS AND DISCUSSION

Intrinsic fluorescence analysis
There is only one tryptophan located at position 214 along the http://bmbreports.org BMB reports chain, in sub domain IIA of HSA, one of the two principal binding sites on HSA (20) (21) (22) . Tryptophan 214 fluorescence is the most frequently examined among the three intrinsic aromatic fluorophores in HSA molecules to obtain information about conformational changes of the protein (21) . The intrinsic fluorescence of the HSA at different temperatures (27, 37, 42 and 47 o C) at 335 nm with varying concentrations of Pt(II) complex are represented in Fig. 2 . As shown in Fig. 2 , the Pt(II) complex, reduces the intrinsic fluorescence emission of protein markedly at different concentrations, then quenches it. Depending on the temperature, maximal quenching of protein was achieved at different concentrations of complex. As it is shown in Fig. 2 , by increasing the temperature from 27 up to 47 o C, the maximal quenching in the fluorescence intensity is observed in lower concentrations of Pt(II) complex.
Analysis of binding equilibria
Florescence quenching data from interaction of complexes and HSA were analyzed to obtain various binding parameters. The binding constant (K) and number of binding (n) were calculated according to the equation (22): Considering the dependence of binding constant on temperature, a thermodynamic process was considered to be responsible for the formation of the complex (24, 25) . Therefore, the dependence of thermodynamic parameters on the temperature was analyzed in order to further characterize the acting forces between Pt(II) complexes and HSA. The acting forces between a small molecule and macromolecule include hydrogen bond, Van der Waals force, electrostatic force, hydrophobic interaction force, and so on (25) (26) (27) . The thermodynamic binding parameters of enthalpy change (ΔH o ) and entropy change (ΔS o ) were determined using van't Hoff equation (23): 
Where R is the gas constant. are usually considered as the evidence for hydrogen bonding between complex and HSA (25) . Therefore, it can be concluded that hydrogen bonding interaction might play a major role in the interactions of Pt(II) complex with HSA at different temperatures.
CD studies
The far-UV CD spectra characterize the secondary structure of proteins due to the peptide bond absorption, whereas the molar ellipticities at 222 nm ( From above results (Fluorescence and CD data), it can be concluded that binding of the new designed drug (Pt(II) complex) on blood carrier protein of HSA resulted significantly changes on the structure and conformation of protein via increasing of stability of HSA, then induces more compacted structure in HSA.
Cytotoxicity measurements of the Pt(II) complex
The in vitro anti-tumor property of the synthesized Pt(II) complex was studied by testing it on human tumor cell line K562. In this study, various concentrations of Pt(II) complex ranging from 0 to 100 μM were used to culture of the tumor cell lines for 24, 48 and 72 h (Fig. 4) . The 50% cytotoxic concentration (Cc50) of the complex was determined from Fig. 4 . which shows that the Cc50 values of the complex after 24, 48 and 72 h incubation time are more than 100 μM (Cc50 ＞100 μM). As shown in Fig. 4 , cell growing after different incubation times was significantly reduced by various concentrations of complex. Also, it is clear that the Pt(II) complex produced a dose and time -response suppression on growing of K562 leukemia cell lines. It can be noticed that the presence of glycinato moiety in the structure of Pt(II) complex has a great influence on the growth suppression activity of this complex on K562 cells.
Quantization of apoptosis by fluorescent labeling
DAPI staining assay revealed typical morphology features of apoptotic cells. Morphological changes of apoptotic cells such as nuclear apoptotic bodies were analyzed by fluorescence microscopy with DAPI. Human leukemic K562 cells were treated with Cc50 concentrations of Pt (II) complex for 24 h incubation time (inset of Fig. 4 ).
Fluorescence staining with DAPI revealed some typical nuclear changes which are characteristic of apoptosis. A few http://bmbreports.org BMB reports apoptotic cells were observed at Cc50 of Pt (II) complex after 24 h incubation time. Above results suggest that Pt (II) complex is a promising anti-proliferative agent and should execute its biological effects by inducing apoptosis. Understanding the mechanisms by which anti-proliferative drugs induces cell death by apoptosis is part of a strategy to treat human tumors; therefore, studies concerning the mechanisms of the apoptotic effects of this compound on leukemia cancer cells merit to be further clarified by in vitro and in vivo studies.
MATERIALS AND METHODS
Materials
Human serum albumin (HSA) was purchased from Sigma. All other materials and reagents were of analytical grades, and solutions were made in double-distilled water. NaCl solution, with 5 mM concentration, was used as a solvent. Since Pt(II) complexes did not dissolve in any buffers with pH 7, then we have to dissolve them in NaCl (5 mM). Concentrations of HSA were determined spctrophotometrically by using, for the calculation, a molecular absorption coefficient of ε 
Synthesis of CH3-(CH2)3-NH-CH2-COOH.HCl
The preparation of this compound followed the published synthesis for CH3-(CH2)7-NH-CH2-COOH.HCl (28) (29) (30) 
Fluorescence measurements
Fluorescence intensity of protein (4.5 μM) measurements was carried out on a Cary spectrofluorimeter model by applying a 1-cm path length fluorescence cuvette. The excitation wavelength was adjusted at 280 nm and the emission spectra were recorded for all of the samples at different temperatures (27, 37, 42 ) based on a mean amino acid residue weight of 113.7 (MRW). The molar ellipticity was determined as [θ]λ= (100 × MRW × θobs/cl), where θobs is the observed ellipticity in degrees at a given wavelength, c is the protein concentration in mg/ml and l is the length of the light path in mm. The CD software was used to predict the secondary structure of the protein according to the statistical method (31, 32) .
Cytotoxic studies Cell culture
In RPMI medium cells were grown. This medium was supplemented with L-glutamine (2 mM), Streptomycin and penicillin (5 μg/ml) and 10% heat-inactivated fetal calf serum, at 37 o C under a 5% CO2/95% air atmosphere.
Cell proliferation assay
The above Pt(II) complexes inhibits the growth of chronic myelogenous leukemia cell line, K562. This growth inhibition was measured by means of MTT assay (24) . The cleavage and conversion of the soluble yellowish MTT to the insoluble purple formazan by active mitochondrial dehydrogenase of living cells has been used to develop an assay system alternative to other assays for measurement of cell proliferation. Harvested cells were seeded in to 96-well plate (1 × 10 4 cell/ml) with varying concentrations of the sterilized drugs (0-100 μM) and incubated for 24, 48 and 72 h. Four hours to the end of incubations, 25 μl of MTT solution (5 mg/ml in PBS) was added to each well containing fresh and cultured medium. At the end, the insoluble formazan produced was dissolved in solution containing 10% SDS and 50% DMF (Left for 2h at 37 o C in dark conditions) and optical density (OD) was read against reagent blank with multi well scanning spectrophotometer (ELISA reader, Model Expert 96, Asys Hitchech, Austria) at a wavelength of 570 nm. Absorbance is a function of concentration of converted dye. The OD value of study groups was divided by the OD value of untreated control and presented as percentage of control (as 100%).
Quantitation of apoptosis by fluorescent labeling
4,6-diamidino-2-phenylindole (DAPI, that purchased from Sigma) staining procedure was detailed previously (33) . In this process, cells were washed once with phosphate buffered saline (PBS), and then resuspended in PBS, containing 0.1% Triton X (to induce holes in the cells membrane increase permeability) and incubated for 10 min on ice. Then, cells down and resuspend them in 4% PBS buffered paraformaldehyde sol-http://bmbreports.org ution containing DAPI. 10 μl of this suspension are placed on a slide glass and covered with a cover slip. The morphology of the cells' nuclei is observed using a fluorescence microscope (Nikon Co., Japan) at excitation wavelength of 350 nm. Apoptotic cells were identified as those showing condensed chromatin or apparently fragmented nuclei. Approximately 500 cells were scored for each condition.
